NEAR THE END OF THIS MONTH there will be an exciting, important and informative conference bringing together many of the world’s scientists and medical doctors who are focused on Ebola.
The title of the conference is Targeting Ebola: Recent Advances and Strategies.
There will be presentations by epidemiologists, drug developers, vaccine developers and a presentation on early detection (diagnostics), molecular biologists, structural biologists, results from clinical trials, information on immune responses in bats, and more.
I am very interested to learn the possibility of late-stage EVD treatment of vascular leak by Petra Wülfroth of F4 Pharma in Germany. This is really new.
From the program:
“While there is no licensed treatment yet available for EVD, a range of blood, immunological and drug therapies are under development and two potential vaccine candidates are undergoing evaluation, according to the WHO. Targeting Ebola 2015 will provide a unique and cutting edge conference to discuss the recent advances, strategies and challenges of all Ebola fields. The keynote lectures given by leading scientists, as well as poster presentations covering various aspects of Ebola infection. During Ebola 2015 a Practical approach will address and discuss different strategies and challenges (short and long term) across the entire innovation cycle. We will discuss about the vaccine candidates available and the ability to roll out clinical trial vaccination programmes in EU / Africa, and how to conduct studies in areas where Ebola virus disease is endemic. We will highlight how a rapid diagnostics can detect EVD at acceptable costs and with very high sensitivity and specificity. We will invite academics and industrials to discuss strategies to treat Ebola infection by innovative drugs, Immunotherapy and others. We will take en consideration the Ethical and political issues of this strategic problem. The topics of the Ebola 2015 cover many sessions:
*Ebola virus disease: where are we now and where do we go?
*The Hemorrhagic Fever Viruses: Recent Advances
*Virus-Host Interactions: State-of-the-Art
*Epidemiology: The Current Situation
*The Diagnostic Tools
*Treatment & Vaccines
*Operational Researches: Present & Future”
I have been asked to write a summary of the proceedings of the meeting for the web, so watch this space!